رفتن به محتوا

تداخل‌های دارویی

Abatacept + Denosumab

شدت: متوسط

Abatacept and Denosumab: moderate interaction.

آخرین به‌روزرسانی

ویژه کادر درمان — فقط جهت مرجع. این صفحه خلاصه‌ای کوتاه است، توصیه پزشکی نیست و جایگزین بروشور رسمی یا قضاوت بالینی نمی‌شود. پیش از تجویز یا تحویل دارو همیشه بررسی کنید.

محتوای بالینی این صفحه فقط به زبان انگلیسی موجود است.

خلاصه

Both agents carry a labeled risk of serious infection, and denosumab labeling advises caution in patients on immunosuppressants. Combining them with abatacept may increase the chance of serious infections, including skin infections.

معنای این تداخل به زبان ساده

Abatacept and Denosumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Abatacept belongs to Musculoskeletal; Denosumab belongs to Oncology.

سطح شواهد: Low

چرا رخ می‌دهد

Additive infection risk from T-cell costimulation blockade (abatacept) and RANKL inhibition with possible immune effects (denosumab); no firm pharmacokinetic mechanism.

اقدام لازم

Monitor for signs of infection, especially cellulitis and other skin infections, and treat early. Interrupt therapy if a serious infection occurs.

از داروساز چه بپرسید

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

ویژه اعضای Pro+

باز کردن کل صفحه

یک حساب بسازید و دوره آزمایشی Pro+ را شروع کنید تا توصیه‌های کامل مدیریت Abatacept و Denosumab، یادداشت‌های تکمیلی، جزئیات شواهد و بررسی‌کننده تداخل برای کل نسخه را باز کنید.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Pro+ را ۱۴ روز رایگان در وب امتحان کنید. بدون نیاز به کارت.

پرسش‌های متداول

Can I take Abatacept with Denosumab?

MediHelp rates the interaction as moderate. Abatacept and Denosumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both agents carry a labeled risk of serious infection, and denosumab labeling advises caution in patients on immunosuppressants. Combining them with abatacept may increase the chance of serious infections, including skin infections.

How serious is the interaction between Abatacept and Denosumab?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for signs of infection, especially cellulitis and other skin infections, and treat early. Interrupt therapy if a serious infection occurs.

What other medicines interact with Abatacept?

MediHelp also lists interactions of Abatacept with, for example, Adalimumab, Adenovirus types 4 and 7 live, Anakinra. The full list is on the Abatacept page.

تک‌نگاری کامل، دوزاژ و بررسی تداخل دارویی در برنامه MediHelp

مرجع کامل را باز کنید، تداخل چند دارو را بررسی کنید و از ابزارهای دوز در برنامه MediHelp استفاده کنید.

مرور از A تا Z · تداخل‌های دارویی

دریافت برنامه ورود